JP2003284553A - 生理活性タンパク質 - Google Patents

生理活性タンパク質

Info

Publication number
JP2003284553A
JP2003284553A JP2002090847A JP2002090847A JP2003284553A JP 2003284553 A JP2003284553 A JP 2003284553A JP 2002090847 A JP2002090847 A JP 2002090847A JP 2002090847 A JP2002090847 A JP 2002090847A JP 2003284553 A JP2003284553 A JP 2003284553A
Authority
JP
Japan
Prior art keywords
lys
asn
asp
leu
gly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002090847A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003284553A5 (enExample
Inventor
Osamu Matsushita
治 松下
Nozomi Nishi
望 西
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikagaku Corp
Original Assignee
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corp filed Critical Seikagaku Corp
Priority to JP2002090847A priority Critical patent/JP2003284553A/ja
Publication of JP2003284553A publication Critical patent/JP2003284553A/ja
Publication of JP2003284553A5 publication Critical patent/JP2003284553A5/ja
Pending legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2002090847A 2002-03-28 2002-03-28 生理活性タンパク質 Pending JP2003284553A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002090847A JP2003284553A (ja) 2002-03-28 2002-03-28 生理活性タンパク質

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002090847A JP2003284553A (ja) 2002-03-28 2002-03-28 生理活性タンパク質

Publications (2)

Publication Number Publication Date
JP2003284553A true JP2003284553A (ja) 2003-10-07
JP2003284553A5 JP2003284553A5 (enExample) 2005-09-02

Family

ID=29236087

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002090847A Pending JP2003284553A (ja) 2002-03-28 2002-03-28 生理活性タンパク質

Country Status (1)

Country Link
JP (1) JP2003284553A (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1774959A1 (fr) * 2005-09-21 2007-04-18 L'Oréal Oligonucléotide d'ARN double brin inhibant l'expression de la tyrosinase
WO2010058707A1 (ja) * 2008-11-19 2010-05-27 明治製菓株式会社 アフィニティタグが結合した融合コラゲナーゼおよびその製造法
US9757435B2 (en) 2012-01-12 2017-09-12 Endo Global Ventures Clostridium histolyticum enzymes and methods for the use thereof
US11123280B2 (en) 2017-03-01 2021-09-21 Endo Ventures Limited Method of assessing and treating cellulite
US11473074B2 (en) 2017-03-28 2022-10-18 Endo Global Aesthetics Limited Method of producing collagenase
US11624060B2 (en) * 2017-02-10 2023-04-11 The Board Of Trustees Of The University Of Arkansas Collagen-binding agent compositions and methods of using the same
US12403179B2 (en) 2021-02-18 2025-09-02 The Board Of Trustees Of The University Of Arkansas Release of growth factors at wound healing stages

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8410260B2 (en) 2005-09-21 2013-04-02 L'oreal Double-stranded RNA oligonucleotides which inhibit tyrosinase expression
US8822428B2 (en) 2005-09-21 2014-09-02 L'oreal Double-stranded RNA oligonucleotides which inhibit tyrosinase expression
EP1774959A1 (fr) * 2005-09-21 2007-04-18 L'Oréal Oligonucléotide d'ARN double brin inhibant l'expression de la tyrosinase
WO2010058707A1 (ja) * 2008-11-19 2010-05-27 明治製菓株式会社 アフィニティタグが結合した融合コラゲナーゼおよびその製造法
US11879141B2 (en) 2012-01-12 2024-01-23 Endo Global Ventures Nucleic acid molecules encoding clostridium histolyticum collagenase II and methods of producing the same
US9757435B2 (en) 2012-01-12 2017-09-12 Endo Global Ventures Clostridium histolyticum enzymes and methods for the use thereof
US12263209B2 (en) 2012-01-12 2025-04-01 Endo Biologics Limited Pharmaceutical compositions comprising collagenase I and collagenase II
US11975054B2 (en) 2012-01-12 2024-05-07 Endo Global Ventures Nucleic acid molecules encoding clostridium histolyticum collagenase I and methods of producing the same
US11624060B2 (en) * 2017-02-10 2023-04-11 The Board Of Trustees Of The University Of Arkansas Collagen-binding agent compositions and methods of using the same
US11813347B2 (en) 2017-03-01 2023-11-14 Endo Ventures Limited Method of assessing and treating cellulite
US11123280B2 (en) 2017-03-01 2021-09-21 Endo Ventures Limited Method of assessing and treating cellulite
US12403081B2 (en) 2017-03-01 2025-09-02 Endo Operations Limited Method of assessing and treating cellulite
US11473074B2 (en) 2017-03-28 2022-10-18 Endo Global Aesthetics Limited Method of producing collagenase
US12448615B2 (en) 2017-03-28 2025-10-21 Endo Operations Limited Method of purifying and isolating collagenase
US12644108B2 (en) 2017-03-28 2026-06-02 Endo Operations Limited Process intermediate in the purification of collagenase drug substances
US12403179B2 (en) 2021-02-18 2025-09-02 The Board Of Trustees Of The University Of Arkansas Release of growth factors at wound healing stages

Similar Documents

Publication Publication Date Title
AU2019282149B2 (en) RNA-guided nucleases and active fragments and variants thereof and methods of use
CN100516220C (zh) 双岐杆菌的丝氨酸蛋白酶抑制剂
KR101476458B1 (ko) 프로테아제 스크리닝 방법 및 이에 의해 확인된 프로테아제
KR20210055733A (ko) 핵염기 편집 시스템을 전달하기 위한 조성물 및 방법
CN101517074B (zh) 蛋白酶筛选方法及由此鉴别的蛋白酶
KR20190082318A (ko) Crispr/cpf1 시스템 및 방법
Engel et al. Murein-metabolizing enzymes from Escherichia coli: existence of a second lytic transglycosylase
CN111499725A (zh) 结合IL-4受体α的泪脂质运载蛋白突变蛋白
CN111788304B (zh) 基因工程噬菌体
Jedrzejas et al. Expression and Purification ofStreptococcus pneumoniaeHyaluronate Lyase fromEscherichia coli
KR102224897B1 (ko) 신규한 폴리펩타이드 및 이를 포함하는 그람음성균에 대한 항생제
WO1993008289A1 (en) HEPARINASE GENE FROM $i(FLAVOBACTERIUM HEPARINUM)
CA2183253A1 (en) Rna editing enzyme and methods of use thereof
CN114502726A (zh) 基因工程化的噬菌体
Richter et al. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies
JP2002078489A (ja) セリン残基が活性発現に関与する新規酸性プロテアーゼ
CN101899469B (zh) 一种穿梭质粒、以及高效表达杀菌肽与溶菌酶基因的方法
JPH07213280A (ja) 耐熱性エステラーゼ
KR101106262B1 (ko) 인간 호메오 도메인 유전자 유래의 단백질 도입 도메인 및 이를 이용한 단백질 도입 벡터
JPH10504452A (ja) 新規トポイソメラーゼｉｖ、対応するヌクレオチド配列およびその使用
JP3536049B2 (ja) 変異型カナマイシンヌクレオチジルトランスフェラーゼ及びこれを用いた好熱菌のスクリーニング方法
CN115362370A (zh) 新颖的杀昆虫毒素受体和使用方法
JP3512237B2 (ja) 耐熱性メチオニンアミノペプチダーゼ及びその遺伝子
Gaur et al. Role of aspartic acid 121 in human pancreatic ribonuclease catalysis
JP4191479B2 (ja) エビのアルカリホスファターゼ

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050301

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050301

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050301

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071018

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071212

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20071212

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080430